Analytical assessment of prognostic factors according to US Institute of Cancer in monitoring the treatment of 292 subjects of mast blastocytoma in pregnancy with the threshold of beta-HCG < 5 UI/l
- Author:
Pham Huy Hien Hoa
- Publication Type:Journal Article
- Keywords:
mast blastocytoma, pregnant women, cancer
- MeSH:
Pregnancy;
Pregnant Women;
Women;
Prognosis
- From:Journal of Practical Medicine
2003;425(5):29-32
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
292 patients with mast blastocytoma who were diagnosed after hydatiform pregnancy, after birth and post pregnancy basing on the examinations of beta-HCG, of matastasis and of anapathology, treated till beta HCG < 5 UI/l. According to US classification, the age of the group 1 (non metastasis ligh mast blastocytoma) is younger than group 2 (metastasis severe mast blastocytoma) and in the group 2 the duration from termination of pregnancy to detection of the condition is longer than group 1. In the group of mast blastocytoma of severe prognosis there are an uterus damage of chorion carcinoma, an invasive hydatiform pregnancy. The simple resistance to chemiotherapy is more dramatical in the group 2 than the group 1
